CE vs HOTH · rev $10.28B vs rev $1.24B
Celanese Corporation (CE) versus Hoth Therapeutics Inc (HOTH) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
CE currently screens at market cap $5.92B. HOTH currently screens at market cap $15.5M.
Not investment advice. Open the CE and HOTH stock pages for the full models.
Not investment advice.